The human serine protease inhibitor, Kazal type 1 (SPINK1), plays a critical role in inhibiting intrapancreatic trypsinogen activation and is considered a key mechanism in preventing the development of pancreatitis. This evidence concerns the gene SPINK1 and pancreatitis.